Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Issue: Health products
Remove filter for
Last updated: 2022
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20221 results available
- November 20221 results available
- October 20222 results available
- September 20221 results available
- August 20226 results available
- July 20222 results available
- June 20222 results available
- May 20221 results available
- April 20222 results available
- March 20223 results available
- February 20222 results available
- January 20223 results available
Displaying 1 - 15 of 26 items.
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
AlertHealth professional risk communication | 2022-12-05
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
AlertHealth professional risk communication | 2022-10-31
Children’s ibuprofen/acetaminophen shortage: What you should know and do
AlertPublic advisory | 2022-10-07
Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario
AlertPublic advisory | 2022-09-06
IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
AlertHealth professional risk communication | 2022-08-29
Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets
AlertPublic advisory | 2022-08-27
Counterfeit Viagra and Cialis erectile dysfunction drugs seized from Grace Daily Mart in Scarborough, Ontario
AlertPublic advisory | 2022-08-25
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20
Taro-Zoledronic acid injection drug, used for osteoporosis and Page's disease, recalled because it may contain particulate matter
AlertPublic advisory | 2022-08-09
Jamp-Atorvastatin 40 mg tablets recalled due to risk of latex contamination
AlertPublic advisory | 2022-08-06
Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity
AlertPublic advisory | 2022-07-28
Buying health products online? Know the risks
AlertPublic advisory | 2022-07-20
Unauthorized health products seized from three herbal medicine stores in Calgary, Alberta
AlertPublic advisory | 2022-06-16
Unauthorized products may pose serious health risks (March 26, 2021 to June 3, 2022)
AlertPublic advisory | 2022-06-03